TTNP
Titan Pharmaceuticals, Inc. | Healthcare
-4.08805%
Analisi Pre-Earnings (Antonio AI)
2025-12-18Sentiment
10.0/100
Salute
Weak
Verdict
This isn't a business, it's a corporate shell game of mergers and lawsuits. 📉 The only run-up here is their legal bill. Avoid this trash at all costs. ⚠️
Catalysts
- Speculative pops based on announcements of yet another merger or financing deal.
- A miraculous resolution to the numerous shareholder lawsuits.
Rischi
- High probability of further dilution from convertible shares, delisting from the exchange, or another value-destroying reverse stock split.
Valutazione
| P/E (TTM) | -1.149848857644991 |
| Forward P/E | -1.149848857644991 |
| P/S | 311.2748 |
| Market Cap | 4057214 |
Finanze & Debito
| Cash | None |
| Debt | None |
| Debt/Equity | 0.0 |
| Current Ratio | 7.556291390728477 |
Redditività
| ROE | -1.2519251925192518 |
| Profit Margin | -284.5 |
| Operating Margin | -263.4 |
| Rev. Growth | -1.0 |
Ultime News (Context per AI)
-
Titan Pharmaceuticals, Inc. Announces Closing of Merger with Black Titan Corporation 2025-10-03 17:26:00
globenewswire.com
-
TITAN PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Titan Pharmaceuticals, Inc. - TTNP 2025-08-05 21:24:00
businesswire.com
-
URGENT: The M&A Class Action Firm Encourages $hareholders to Act Before Vote – Titan Pharmaceuticals, Inc. (Nasdaq: TTNP) 2025-07-29 11:26:00
globenewswire.com
-
Titan Pharmaceuticals Announces $600,000 Private Placement of Convertible Preferred Stock 2025-06-27 16:05:00
globenewswire.com
-
Titan Pharmaceuticals Announces Filing of Registration Statement for Proposed Business Combination with TalenTec Sdn. Bhd. 2025-06-03 08:45:00
globenewswire.com
-
Titan Pharmaceuticals Announces $1 Million Private Placement of Convertible Preferred Stock 2025-04-11 16:15:00
globenewswire.com
-
North American Morning Briefing : Global Ad Shares -2- 2024-12-09 06:35:38
https://www.marketscreener.com
-
Titan Pharmaceuticals, Inc. Announces Receipt of Notice from Nasdaq 2024-11-27 16:05:00
globenewswire.com
-
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Titan Pharmaceuticals, Inc. – TTNP 2024-09-05 16:32:00
globenewswire.com
-
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Titan Pharmaceuticals, Inc. - TTNP 2024-09-04 18:31:00
prnewswire.com
-
Shareholder Alert: Ademi LLP investigates whether Titan Pharmaceuticals, Inc. has obtained a Fair Price for its Public Shareholders 2024-08-23 13:07:00
prnewswire.com
-
TTNP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Titan Pharmaceuticals, Inc. Is Fair to Shareholders 2024-08-19 19:30:00
businesswire.com
-
Titan Pharmaceuticals Enters Into Merger Agreement With KE Sdn. Bhd. 2024-08-19 16:11:00
globenewswire.com
-
Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria 2024-01-25 16:29:00
globenewswire.com
-
Titan Pharmaceuticals Announces Reverse Stock Split and Ratio 2023-12-28 16:15:00
globenewswire.com